Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG

Biological Research

Volumn 43, Issue 1, 2010, Pages 13-18

  Seixas, Fabiana K ^a   Borsuk, Sibele ^a   Fagundes, Michel Q ^a   Hartwig, Daiane D ^a   da Silva, Éverton F ^a   Cerqueira, Gustavo M ^a   Dellagostin, Odir A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Auxotrophic complementation; Foreign antigens; Recombinant BCG

Indexed keywords

CRICETINAE; LEPTOSPIRA INTERROGANS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM LEPRAE;

EID: 77953715938     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602010000100003     Document Type: Article

References (22)

1. ABOMOELAK B, HUYGEN K, KREMER L, TURNEER M, & LOCHT C (1999). Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein. Infect Immun 67: 5100-5105.
2. BANGE FC, BROWN AM, & JACOBS WR, JR. (1996). Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 64: 1794-1799.
3. BASTOS RG, BORSUK S, SEIXAS FK, & DELLAGOSTIN OA (2009). Recombinant Mycobacterium bovis BCG. Vaccine 27: 6495-6503.
4. BASTOS RG, DELLAGOSTIN OA, BARLETTA RG, DOSTER AR, NELSON E, & OSORIO FA (2002). Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 21: 21-29.
5. BORSUK S, MENDUM TA, FAGUNDES MQ, MICHELON M, CUNHA CW, MCFADDEN J, & DELLAGOSTIN OA (2007). Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG. Tuberculosis 87: 474-480.
6. BUDDLE BM, DE LISLE GW, PFEFFER A, & ALDWELL FE (1995). Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13: 1123-1130.
7. CONNELL ND, MEDINA-ACOSTA E, MCMASTER WR, BLOOM BR, & RUSSELL DG (1993). Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci U S A 90: 11473-11477.
8. DA SILVA RAMOS RA, CONCEICAO FR, GRASSMANN AA, LAGRANHA VL, & DELLAGOSTIN OA (2008). B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination. Can J Microbiol 54: 677-686.
9. DELLAGOSTIN OA, WALL S, NORMAN E, O'SHAUGHNESSY T, DALE JW, & MCFADDEN J (1993). Construction and use of integrative vectors to express foreign genes in mycobacteria. Mol Microbiol 10: 983-993.
10. DEMANGEL C, GARNIER T, ROSENKRANDS I, & COLE ST (2005). Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 73: 2190-2196.
11. DENNEHY M, BOURN W, STEELE D, & WILLIAMSON AL (2007). Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Vaccine 25: 3646-3657.
12. DENNEHY M & WILLIAMSON AL (2005). Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23: 1209-1224.
13. EDELMAN R, PALMER K, RUSS KG, SECREST HP, BECKER JA, BODISON SA, PERRY JG, SILLS AR, BARBOUR AG, LUKE CJ, HANSON MS, STOVER CK, BURLEIN JE, BANSAL GP, CONNOR EM, & KOENIG S (1999). Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. Vaccine 17: 904-914.
14. FERNANDES CP, SEIXAS FK, COUTINHO ML, VASCONCELLOS FA, SEYFFERT N, CRODA J, MCBRIDE AJ, KO AI, DELLAGOSTIN OA, & ALEIXO JA (2007). Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic Leptospira: production, characterization, and testing in diagnostic applications. Hybridoma 26: 35-41.
15. MEDEIROS MA, DELLAGOSTIN OA, ARMOA GR, DEGRAVE WM, MENDONCA-LIMA L, LOPES MQ, COSTA JF, MCFADDEN J, & MCINTOSH D (2002). Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics. Microbiology 148: 1999-2009.
16. MEDERLE I, BOURGUIN I, ENSERGUEIX D, BADELL E, MONIZ-PEIREIRA J, GICQUEL B, & WINTER N (2002). Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect Immun 70: 303-314.
17. MICHELON A, CONCEIÇÃO FR, BINSFELD PC, DA CUNHA CW, MOREIRA AN, ARGONDIZZO AP, MCINTOSH D, ARMOA GR, CAMPOS AS, FARBER M, MCFADDEN J, & DELLAGOSTIN OA (2006). Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen. Vaccine 24: 6332-6339.
18. PARISH T & STOKER NG (1998). Electroporation of mycobacteria. Methods Mol Biol 101: 129-144.
19. SEIXAS FK, DA SILVA EF, HARTWIG DD, CERQUEIRA GM, AMARAL M, FAGUNDES MQ, DOSSA RG, & DELLAGOSTIN OA (2007a). Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26: 88-95.
20. SEIXAS FK, FERNANDES CH, HARTWIG DD, CONCEIÇÃO FR, ALEIXO JA, & DELLAGOSTIN OA (2007b). Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can J Microbiol 53: 472-479.
21. STOVER CK, DE LC, V, FUERST TR, BURLEIN JE, BENSON LA, BENNETT LT, BANSAL GP, YOUNG JF, LEE MH, HATFULL GF. (1991). New use of BCG for recombinant vaccines. Nature 351: 456-460.
22. VARALDO PB, LEITE LC, DIAS WO, MIYAJI EN, TORRES FI, GEBARA VC, ARMOA GR, CAMPOS AS, MATOS DC, WINTER N, GICQUEL B, VILAR MM, MCFADDEN J, ALMEIDA MS, TENDLER M, & MCINTOSH D (2004). Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun 72: 3336-3343.